Ticker League

Cash on Hand for Edwards Lifesciences (EW)

As of · Reported

Metric

Latest period

$3.67B

YoY change

+6.3%

5Y CAGR

+24.7%

Peak year (2025)

$4.23B

Cash on Hand history chart for Edwards Lifesciences (EW) from 1999 to 2025

Latest: $4.23B

Cash on Hand growth chart for Edwards Lifesciences (EW) from 1999 to 2025

Latest: +6.3%

Cash on Hand history table for Edwards Lifesciences (EW) from 1999 to 2025

  • 2025$4.23B+6.3%
  • 2024$3.98B+143.5%
  • 2023$1.63B+34.4%
  • 2022$1.22B-17.1%
  • 2021$1.47B+4.6%
  • 2020$1.40B-7.5%
  • 2019$1.52B+58.6%
  • 2018$956.50M-28.5%
  • 2017$1.34B+5.2%
  • 2016$1.27B+3.8%
  • 2015$1.22B-14.9%
  • 2014$1.44B+53.6%
  • 2013$936.90M+79.7%
  • 2012$521.40M+15.7%
  • 2011$450.50M+13.7%
  • 2010$396.10M+18.6%
  • 2009$334.10M+47.3%
  • 2008$226.80M+18.6%
  • 2007$191.20M+4.6%
  • 2006$182.80M+2.4%
  • 2005$178.60M+265.2%
  • 2004$48.90M-20.0%
  • 2003$61.10M+78.7%
  • 2002$34.20M-28.7%
  • 2001$48.00M+71.4%
  • 2000$28.00M—
  • 1999$0.00—

Cash on Hand values are taken from Edwards Lifesciences's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Cash on Hand at Edwards Lifesciences (EW)

According to Edwards Lifesciences's latest reported financial statements, the company's latest reported cash and short-term investments is $3.67B. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for net leverage and total assets for the share of assets held in cash.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

In 2025, Edwards Lifesciences (EW) cash and short-term investments totalled $4.23B – grew 6.3% year-over-year.

Across 2020–2025 (5 years), Edwards Lifesciences cash and short-term investments produced a CAGR of +24.7% – sustaining 3 straight years of year-over-year growth.

The record annual cash and short-term investments stands at $4.23B, reached in 2025; the historical low of $0.00 was recorded in 1999.

Edwards Lifesciences Cash on Hand by Year

Edwards Lifesciences Cash on Hand 2025: $4.23B

2025's cash and short-term investments for Edwards Lifesciences came in at $4.23B, grew 6.3% from 2024. This figure represents the highest annual value in the available history.

Edwards Lifesciences Cash on Hand 2024: $3.98B

Edwards Lifesciences posted cash and short-term investments of $3.98B in 2024, surged 143.5% from 2023.

Edwards Lifesciences Cash on Hand 2023: $1.63B

In 2023, Edwards Lifesciences reported cash and short-term investments of $1.63B, surged 34.4% from 2022.

Edwards Lifesciences Cash on Hand 2022: $1.22B

Edwards Lifesciences cash and short-term investments in 2022 was $1.22B, declined 17.1% below 2021.

Edwards Lifesciences Cash on Hand 2021: $1.47B

Edwards Lifesciences cash and short-term investments in 2021 was $1.47B.

See more financial history for Edwards Lifesciences (EW).

Sector peers by Cash on Hand

Healthcare peers of Edwards Lifesciences (EW), ranked by their latest cash and short-term investments

Frequently asked questions

Edwards Lifesciences (EW) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview